West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$318.02 USD
+0.10 (0.03%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $318.06 +0.04 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Brokerage Reports
0 items in cart
West Pharmaceutical Services, Inc. [WST]
Reports for Purchase
Showing records 101 - 110 ( 110 total )
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Hydraulic Presses for Biotechnology Success; 4Q and FY21 Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Bioproduction: ''Guten Morgan Europe'' - Positive 2021 Industry Guides from Lonza and Sartorius
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Initiating at Overweight - Best Franchise in Healthcare? We Think So
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department